Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Other Gross PP&E Adjustments: 2015-2025

Historic Other Gross PP&E Adjustments for Aytu Biopharma (AYTU) over the last 11 years, with Sep 2025 value amounting to -$2.4 million.

  • Aytu Biopharma's Other Gross PP&E Adjustments fell 0.87% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.2 million, marking a year-over-year decrease of 194.91%. This contributed to the annual value of -$1.2 million for FY2025, which is 261.23% down from last year.
  • Per Aytu Biopharma's latest filing, its Other Gross PP&E Adjustments stood at -$2.4 million for Q3 2025, which was down 106.54% from -$1.2 million recorded in Q2 2025.
  • Over the past 5 years, Aytu Biopharma's Other Gross PP&E Adjustments peaked at $1.5 million during Q1 2023, and registered a low of -$6.7 million during Q3 2021.
  • Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$1.1 million (2025), whereas its average is -$804,455.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 3,627.55% in 2021, then skyrocketed by 4,391.18% in 2023.
  • Quarterly analysis of 5 years shows Aytu Biopharma's Other Gross PP&E Adjustments stood at -$4.7 million in 2021, then spiked by 93.44% to -$307,000 in 2022, then tumbled by 286.64% to -$1.2 million in 2023, then crashed by 111.12% to -$2.5 million in 2024, then declined by 0.87% to -$2.4 million in 2025.
  • Its Other Gross PP&E Adjustments stands at -$2.4 million for Q3 2025, versus -$1.2 million for Q2 2025 and -$1.1 million for Q1 2025.